Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/roivants-risky-hemavant-bet-falls-short-spinout-wind-down-after-ex-eisai-drug
https://www.globenewswire.com//news-release/2024/02/13/2828109/34323/en/Roivant-Reports-Financial-Results-for-the-Third-Quarter-Ended-December-31-2023-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/01/30/2820500/34323/en/Roivant-to-Report-Financial-Results-for-the-Third-Quarter-Ended-December-31-2023-and-Provide-Business-Update-on-Tuesday-February-13-2024.html
https://endpts.com/vivek-ramaswamy-drops-out-of-presidential-race-endorses-trump/
https://www.fiercebiotech.com/biotech/roivants-matt-gline-has-pangs-regret-letting-telavant-go-hes-ready-deal-again
https://www.globenewswire.com//news-release/2023/12/20/2799662/34323/en/Roivant-Reports-Positive-Initial-Phase-2-Results-for-Batoclimab-in-Graves-Disease.html
https://www.globenewswire.com//news-release/2023/12/14/2796336/34323/en/Roche-Completes-Acquisition-of-Telavant-from-Roivant-Including-Rights-to-Novel-TL1A-Directed-Antibody-RVT-3101-for-the-Treatment-of-Inflammatory-Bowel-Disease.html
https://www.reuters.com/business/healthcare-pharmaceuticals/roivant-sciences-lupus-drug-fails-reduce-symptoms-mid-stage-study-2023-11-27/
https://www.globenewswire.com//news-release/2023/11/28/2786807/34323/en/Roivant-Announces-Positive-IMVT-1402-Initial-600-mg-MAD-Results-that-Confirm-Best-in-Class-Potential.html